GlobeNewswire by notified

Equinor ASA: Buy-back of shares to share programmes for employees

Share

Please see below information about transactions made under the buy-back programme for Equinor ASA (OSE:EQNR, NYSE:EQNR) for shares to be used in the share-based incentive programmes for employees and management.

Date on which the buy-back programme was announced: 7 February 2024.

The duration of the buy-back programme: 15 February 2024 to 15 January 2025.

Size of the buy-back programme: The total purchase amount under the programme is NOK 1,156,000,000 and the maximum shares to be acquired is 16,800,000 shares, of which up to 7,400,000 shares can be acquired in the period from 15 February 2024 to 15 May 2024, and up to 9,400,000 shares can be acquired in the period from 16 May 2024 to 15 January 2025.

On 15 February 2024, Equinor ASA has purchased a total of 693,724 own shares at the Oslo Stock Exchange at an average price of NOK 259.4690 per share.

Aggregated overview of transactions per day:

DateAggregated volume (number of shares)Weighted average share price (NOK) Total transaction value (NOK) 
15 February 2024693,724259.4690179,999,873
Previously disclosed buy-backs under the programme (accumulated)
Total buy-backs under the programme693,724259.4690179.999,873


Following the completion of the above transactions, Equinor ASA owns a total of 64,610,186 own shares, corresponding to 2.15% of Equinor ASA’s share capital, including shares purchased under the previous buy-back programme for the share-based incentive programmes for employees, and shares purchased under Equinor’s disclosed buy-back programmes which will be used to reduce the issued share capital of the company.

This is information that Equinor ASA is obliged to make public pursuant to the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Appendix:
A detailed overview of all transactions made under the buy-back programme that have been carried out during the above-mentioned time period is attached to this report and available at www.newsweb.no.

Further information from

Investor relations
Bård Glad Pedersen, senior vice president Investor Relations,
+47 918 01 791

Media
Sissel Rinde, vice president Media Relations,
+ 47 412 60 584


Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Cortus Energy AB deltar på Nordbex projektlansering för satsning på koldioxidnegativ elproduktion i Nybro kommun den 18 april17.4.2024 08:00:00 CEST | Pressemelding

Stockholm, den 17 april 2024 PRESSMEDDELANDE Cortus Energy AB (”Cortus Energy” eller ”Bolaget”) deltar på projektlansering om koldioxidnegativ elproduktion, tillsammans med samarbetsparter Nordbex AB (”Nordbex”). Nordbex presenterar sin satsning och ambitionen att göra Nybro kommun koldioxidnegativ innan 2030 genom ett koldioxidnegativt kraftverk med Cortus Energys förgasningsteknologi, WoodRoll®. Under projektlanseringen kommer den svenska projektutvecklaren Nordbex presentera miljardsatsningen på koldioxidnegativ elproduktion som görs i Nybro kommun. Det första koldioxidnegativa kraftverket ska byggas av Nordbex, där Cortus WoodRoll®-förgasningsteknologi har en central roll till följd av den rena syngasen som produceras. Nordbex kraftverk kommer att generera 135 GWh ren energi och samla in 200 000 ton koldioxid från atmosfären varje år. Projektlanseringen inleds med en presentation av Nordbex, vilken går att följa live från och med kl 16:00 den 18 april på följande länk https://www.y

Norsk Hydro: Reminder - Invitation to Hydro's first quarter results 202417.4.2024 08:00:00 CEST | Press release

Hydro's first quarter results 2024 will be released at 07:00 CEST (01:00 EDT, 06:00 BST, 05:00 UTC/GMT) on Wednesday, April 24, 2024. The quarterly report and presentation will be available on hydro.com at the same time. President and CEO Hilde Merete Aasheim and Executive Vice President, Corporate Development & acting CFO Trond Olaf Christophersen will host a webcast in English at 08:30 CEST the same day. There will be a Q&A session directly after the presentation. There will be no presentation or press conference at our corporate headquarters. To join the webcast and ask questions, register your details in the webcast page. Once registered, you will receive a separate email confirming your registration. The webcast is powered by Livestorm. We advise that you investigate in advance if your company has any restrictions using this platform. Investor contact: Martine Rambøl Hagen +47 91708918 martine.rambol.hagen@hydro.com

Roche’s subcutaneous OCREVUS one-year data demonstrates near-complete suppression of clinical relapses and brain lesions in patients with progressive and relapsing forms of MS17.4.2024 08:00:00 CEST | Press release

Results from the Phase III study showed that subcutaneous (SC) injection was consistent with IV infusion and demonstrated near-complete suppression of relapse activity (97%) and MRI lesions (97.2%) through 48 weeksThe twice-yearly, 10-minute SC injection has the potential to expand the usage of OCREVUS to treatment centres without IV infrastructure or with IV capacity limitationsU.S. FDA and EMA accepted filings based on the data from OCARINA II, with EU approval anticipated mid-2024 and U.S. approval anticipated September 2024 Basel, 17 April 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today data from the Phase III OCARINA II study (S31.006) of OCREVUS® (ocrelizumab), an investigational twice-yearly, 10-minute subcutaneous (SC) injection. Results showed near-complete suppression of clinical relapses and brain lesions in people with relapsing or primary progressive multiple sclerosis (RMS or PPMS) which reinforce the potential benefits of this investigational formulation. Treat

Nilörn Interim Report Q1, 202417.4.2024 08:00:00 CEST | Press release

Period January - March Order intake increased by 5 percent to MSEK 233 (223)Revenue increased by 10 percent to MSEK 242 (221)Revenue adjusted for currency effects amounted to MSEK 243 (221), i.e., an underlying organic increase of 10 percentOperating profit amounted to MSEK 22.5 (16.9)Net profit for the period amounted to MSEK 16.7 (11.1)Earnings per share amounted to SEK 1.46 (0.97)Net cash excluding IFRS 16 amounted to MSEK 8 (43) Significant during the quarter The board has decided to propose to the annual general meeting a dividend of SEK 1.00 (5.00) per share, equivalent to MSEK 11.4 (57.0)Nilorngruppen has initiated a strategic collaboration with Worldfavor, strengthening the Nilorn:CONNECT solution and offer to our customers on their journey towards the Digital Product Passport. A presentation will be held today 17/4 at 08.30 am CET, where the CEO presents the report. You can participate by register on the link below: Registration Form For further information about Nilörn, pleas

Nilörn Delårsrapport Q1, 202417.4.2024 08:00:00 CEST | Pressemelding

Perioden januari - mars Orderingången ökade med 5 procent till 233 (223) MSEKOmsättningen i SEK ökade med 10 procent till 242 (221) MSEKOmsättningen justerat för valutaeffekter uppgick till 243 (221) MSEK, dvs en underliggande organisk ökning om 10 procentRörelseresultatet uppgick till 22,5 (16,9) MSEKPeriodens resultat uppgick till 16,7 (11,1) MSEKResultatet per aktie uppgick till 1,46 (0,97) SEKNettokassan (exklusive IFRS16) uppgick till 8 (43) MSEK Väsentliga händelser under kvartalet Styrelsen har beslutat att föreslå årsstämman en utdelning om 1,00 (5,00) kronor per aktie, motsvarande 11,4 (57,0) MSEKNilörn har inlett ett strategiskt samarbete med Worldfavor, vilket stärker lösningen Nilörn:CONNECT och erbjudandet till våra kunder på deras resa mot det Digitala Produktpasset En presentation kommer hållas idag 17/4 kl. 08.30, där VD presenterar rapporten. Du kan delta genom att registrera dig på nedanstående länk: Registration Form För ytterligare information om Nilörn, kontakta: K

HiddenA line styled icon from Orion Icon Library.Eye